GeneDx Holdings Corp. (NASDAQ: WGS)
$32.04
-2.4600 ( -7.13% ) 607.8K
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets. It has two segments GeneDx, which derives maximum revenue and Legacy Sema4 diagnostics.
Market Data
Open
$32.04
Previous close
$34.50
Volume
607.8K
Market cap
$838.40M
Day range
$31.85 - $36.15
52 week range
$1.16 - $36.15
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | May 31, 2024 |
4 | Insider transactions | 1 | May 28, 2024 |
4 | Insider transactions | 1 | May 15, 2024 |
4 | Insider transactions | 1 | May 03, 2024 |
4 | Insider transactions | 1 | Apr 30, 2024 |
4 | Insider transactions | 1 | Apr 30, 2024 |
10-q | Quarterly Reports | 92 | Apr 29, 2024 |
8-k | 8K-related | 49 | Apr 29, 2024 |
8-k | 8K-related | 18 | Apr 29, 2024 |
ars | Annual reports | 1 | Apr 29, 2024 |